Sungho Bea
Overview
Explore the profile of Sungho Bea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baxter S, Lund L, Andersen J, Brix T, Hegedus L, Hsieh M, et al.
Thyroid
. 2025 Jan;
35(1):69-78.
PMID: 39772758
Concerns have been raised that glucagon-like peptide 1 receptor agonists (GLP1-RAs) may increase the risk of thyroid cancer, but evidence remains conflicting. We therefore investigated if GLP1-RA use, compared with...
2.
Bea S, Ahn H, Woo J, Shin J, Cho S
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39657695
Context: Emerging reports have raised concerns regarding the potential link between COVID-19 vaccination and thyroid dysfunction, specifically thyroiditis. Objective: This study aimed to investigate the potential association between COVID-19 vaccination...
3.
Bea S, Huybrechts K, Edrees H, Basham C, Vine S, Glynn R, et al.
J Am Coll Cardiol
. 2024 Oct;
84(16):1578-1581.
PMID: 39384265
No abstract available.
4.
Chen J, Shin J, Bea S, Ye B, Lee D, Kim H, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae535.
PMID: 39355262
Background: Chronic conditions (CCs) may increase the risk of herpes zoster (HZ) infection, leading to a greater healthcare burden in these individuals compared to those without CCs. It is therefore...
5.
Bea S, Ko H, Bae J, Cho Y, Chang Y, Ryu S, et al.
Gut
. 2024 Sep;
74(2):284-294.
PMID: 39242193
Objective: To examine the hepatic effectiveness of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) through a head-to-head comparison with glucagon-like peptide-1 receptor agonists (GLP-1RA) or thiazolidinediones (TZD) in patients with metabolic dysfunction-associated steatotic...
6.
Kim K, Ko H, Bea S, Lee H, Shin J, Chu M
J Clin Neurol
. 2024 Sep;
20(5):529-536.
PMID: 39227336
Background And Purpose: Migraine is one of the most common chronic neurological diseases worldwide. Although diverse treatment regimens have been recommended, there is insufficient evidence for which treatment patterns to...
7.
Hong B, Bea S, Ko H, Kim W, Cho Y, Shin J
Ann Intern Med
. 2024 Aug;
177(10):1319-1329.
PMID: 39186787
Background: Both sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have neuroprotective effects in patients with type 2 diabetes (T2D). However, their comparative effectiveness in preventing...
8.
Choi Y, Lim J, Bea S, Lee J, Choi J, Rho S, et al.
Eur Heart J
. 2024 Jul;
45(32):2983-2991.
PMID: 38993069
Background And Aims: Concerns about the safety of coronavirus disease 2019 (COVID-19) vaccines in patients with atrial fibrillation/flutter (AF/AFL) have arisen due to reports of thrombo-embolic events following COVID-19 vaccination...
9.
Park D, Bea S, Bae J, Lee H, Choe Y, Shin J, et al.
Drugs Real World Outcomes
. 2024 Jul;
11(3):465-475.
PMID: 38954190
Aims: Protein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are novel lipid-lowering agents used in patients with cardiovascular disease. Despite reassuring safety data from pivotal trials, increasing evidence from real-world studies...
10.
Hong B, Bea S, Chan You S, Chang Y, Kim W, Shin J
Am J Med
. 2024 Apr;
137(8):742-750.e11.
PMID: 38641192
Background: Although the effectiveness and safety of ticagrelor versus clopidogrel may differ in patients with chronic liver disease, there is a scarcity of evidence comparing ticagrelor and clopidogrel in patients...